Wang, Denong, and Jiahai Lu. Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV. Physiol Genomics 18: 245-248, 2004. First published May 25, 2004 10.1152/ physiolgenomics.00102.2004.-Using carbohydrate microarrays, we characterized the carbohydrate binding activity of SARS-CoV neutralizing antibodies elicited by an inactivated SARS-CoV vaccine. In these antibodies, we detected undesired autoantibody reactivity specific for the carbohydrate moieties of an abundant human serum glycoprotein asialo-orosomucoid (ASOR). This observation provides important clues for the selection of specific immunologic probes to examine whether SARS-CoV expresses antigenic structures that mimic the host glycan. We found that lectin PHA-L (Phaseolus vulgaris L.), which is specific for a defined complex carbohydrate of ASOR, stained the SARS-CoV-infected cells specifically and intensively. Taken together, we present immunologic evidence that a carbohydrate structure of SARS-CoV shares antigenic similarity with host glycan complex carbohydrates. The experimental approaches we applied in this study are likely applicable for the identification of immunologic targets of other viral pathogens. microarray; carbohydrate; autoantigen; antibody and lectin; asialoorosomucoid SARS-COV IS A NEWLY IDENTIFIED human coronavirus that caused an outbreak of severe acute respiratory syndrome (SARS) (4,8,11). Although substantial efforts have been made to study the etiologic agent of the disease, the carbohydrate structures of SARS-CoV remain largely uncharacterized. In this study, we introduced a glycan array-based approach to probe the carbohydrate-based antigenic structures of SARS-CoV. More specifically, we constructed glycan arrays to display carbohydrate antigens of defined structures and then applied these tools to detect carbohydrate-specific antibody "fingerprints" that were elicited by a SARS vaccine. We reasoned that if SARS-CoV expressed antigenic carbohydrate structures, then immunizing animals using the whole virus-based vaccines would have the possibility to elicit antibodies specific for these structures. In addition, if SARS-CoV displayed a carbohydrate structure that mimics host cellular glycans, then vaccinated animals may develop antibodies with autoimmune reactivity to their corresponding cellular glycans.
EXPERIMENTS AND RESULTSOur laboratory has established a practical bioarray platform for the construction of carbohydrate microarrays (14,16). Using this technology, we constructed a glycan array (Fig. 1, A and B) 1 to display a collection of 51 carbohydrate antigens, including both microbial polysaccharides and cellular glycan complex carbohydrates. Blood group substances A, B, O, Lewis, I, and i antigens, and their precursors and structural derivatives were specially included. These complex carbohydrates are covalently attached to cellular proteins by either Oor N-glycosylation linkages as protein posttranslational modifications or linked to a membrane-bound lipid molecule. Therefore, scanning the antibody...